You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股异动 | 药品股普涨 三生制药(1530.HK)升逾5%领涨
格隆汇 01-09 11:42
格隆汇1月9日丨药品股普涨,三生制药(1530.HK)升5.81%领涨,泰凌医药涨逾4%,翰森制药、四环医药、同仁堂科技涨逾3%,中生制药、中国中药等涨逾2%。个股方面,三生制药日前获JP Morgan增持270.3万股;此前12月底发公告称,拟购回最多约2.53亿股股份,占于股东周年大会日期已发行股份总数10%。中生制药昨晚公告称,研制的预防化疗引起的恶心呕吐药注射用福沙匹坦获欧盟药品上市许可。 板块方面,中信建投称,展望2020年,看好医药行业的结构性投资机会2.0版,建议坚定持有核心资产,同时积极关注具备性价比优势的细分龙头。医药板块近期表现平淡,认为目前是很好的医药布局的时间点。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account